Issue |
Section |
Title |
File |
Vol 83, No 10 (2011) |
Editorial |
Primary immunodeficiency in adults: total variable immune deficiency clinical manifestations, immunological and genetic defects, treatment |
|
Vol 92, No 12 (2020) |
Articles |
BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic |
 (Rus)
|
Vol 93, No 1 (2021) |
Reviews |
BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic |
 (Rus)
|
Vol 94, No 5 (2022) |
Original articles |
Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit |
 (Rus)
|
Vol 95, No 1 (2023) |
Original articles |
Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies |
 (Rus)
|
Vol 95, No 7 (2023) |
Original articles |
Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study) |
 (Rus)
|